Share on LinkedInShare on LinkedIn

ARTICLE · 08 DECEMBER 2020

EMIR Update: Extension Of Relief On Brexit-related Novations

Dillon Eustace
Dillon Eustace
Contributor
Dillon Eustace

Dillon Eustace

Dillon Eustace is one of Ireland’s leading law firms focusing on asset management and investment...

View firm profile
Explore more from Dillon Eustace

The loss of EU financial passporting rights after end of the Brexit transition period will have implications for cross-border OTC derivatives trading between UK and EU counterparties.

IrelandGovernment, Public Sector

Introduction

The loss of EU financial passporting rights after end of the Brexit transition period will have implications for cross-border OTC derivatives trading between UK and EU counterparties. The Brexit transition period is set to expire on 31 December 2020.

Post 31 December 2020, counterparties established in the UK will no longer be able to provide certain services across the EU. In particular, such UK firms will not be able to execute so-called "life-cycle events" on existing OTC contracts with EU counterparties (such as novations, unwinding by entering into an offsetting transaction, compression with new replacement contracts, etc.).

Novation of existing OTC derivative contracts with UK counterparties

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

See more popular content from